US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

67.16 -0.45 (-0.67%)
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity
From Ambry Genetics
Via Business Wire
News headline image
IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio? ↗
Top large-cap losers last week included IonQ, Tempus AI, AeroVironment, Astera Labs, Nebius, Kratos, F5, Klarna, Leonardo DRS, and First Horizon, driven by sector pullbacks, policy concerns on defense... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Whitehawk Therapeutics Dips Over 8% In After-Hours Trading Despite New Tempus AI Partnership ↗
Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading following the news. 
Via Benzinga
Topics Artificial Intelligence
Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Whitehawk Therapeutics Stock Is Trading Higher Thursday: What's Going On? ↗
Whitehawk Therapeutics shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI to support the development of its oncology pipeline. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Hits $100—Are Shares Due for a Pullback? ↗
After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction. 
Via MarketBeat
Topics Artificial Intelligence Government Initial Public Offering
News headline image
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
From Tempus AI, Inc.
Via Business Wire
News headline image
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any? ↗
Shared stocks between Nancy Pelosi and Cathie Wood include Alphabet, Amazon, NVIDIA, and Tempus AI. They also both own stakes in private company Databricks. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025 ↗
Track Nancy Pelosi's 2025 stock trades. Disclosures reveal a Tempus AI (TEM) options buy nets huge gains along with a Broadcom move. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall ↗
Tempus AI (TEM) stock has soared past $100, giving a 60% boost to billionaire Cliff Asness' TEM position in the AI-diagnostic stock. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock ↗
Tempus AI stock nudged higher after hours following insider sales by COO Ryan Fukushima's spouse under a pre-arranged trading plan. 
Via Benzinga
Topics Artificial Intelligence
News headline image
These 5 Beaten-Down Tech Stocks Could Catch Fire Next ↗
Highly shorted stocks with positive growth outlooks and improving market support are set up for short squeezes: this is a look at five. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200% ↗
An AI stock disclosed as a new 2025 purchase by Nancy Pelosi is up over 200% since she took the position in January. 
Via Benzinga
Topics Artificial Intelligence
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Why Tempus AI Stock Was Motoring Higher This Week ↗
A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On? ↗
Shares of Tempus AI Inc (NASDAQ: TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here's what investors need to know. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
From Ambry Genetics
Via Business Wire
News headline image
Affirm Holdings, Oklo, Tempus AI Are Among Top 10 Large Cap Losers Last Week (Sep. 22- Sep. 26): Are The Others In Your Portfolio? ↗
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio? 
Via Benzinga
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks Using AI to Drive Growth ↗
AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation 
Via MarketBeat
Topics Artificial Intelligence
News headline image
What Are 2 Great Tech Stocks to Buy Right Now? ↗
These two tech stocks could deliver big returns for investors willing to hold for the long term. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
7 Analysts Have This To Say About Tempus AI ↗
Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings,... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Tempus AI Stock Is Plunging This Week ↗
When a well-known growth investor decides to trim her position in a stock, investors sit up and take note. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Woth $11 Million, Dumps AMD And This AI Stock ↗
On Wednesday Sept. 24, 2025, Cathie Wood-led Ark Invest purchased nearly $11 million worth of Alibaba stock while selling shares of AMD and Tempus AI. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead ↗
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >